Trastuzumab beyond progression for HER2 positive metastatic breast cancer: Progression-free survival on first-line therapy predicts overall survival impact

Daniel Rayson, Sarah Lutes, Gordon Walsh, Marlene Sellon, Bruce Colwell, Mark Dorreen, Arik Drucker, Alwin Jeyakumar, Tallal Younis

Research output: Contribution to journal › Article › peer-review

13 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Trastuzumab beyond progression for HER2 positive metastatic breast cancer: Progression-free survival on first-line therapy predicts overall survival impact'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology